Transient lowering of the IgA level during Diphedan therapy
Balogh, E.; Máttyus, A.; Németh, C.; Szabadosné, N.M.
Orvosi Hetilap 120(36): 2179-2182
1979
ISSN/ISBN: 0030-6002 PMID: 514604 Document Number: 139219
Document emailed within 1 workday
Related Documents
Mamedov, M.N.; Perova, N.V.; Kosmatova, O.V.; Khadipash, L.A.; Kiseleva, N.V.; Oganov, R.G. 2003: Effect of combined antihypertensive and lipid lowering therapy on the level of coronary risk and tissue insulin resistance in patients with metabolic syndrome Kardiologiia 43(3): 13-19Singh, A.; Bedi, V.P. 1984: Transient paraplegia following sudden lowering of blood pressure Journal of the Indian Medical Association 82(6): 214-5 228
Lemenev, V.L.; Svintradze, R.G.; Kazakov, E.S.; Koshelev, I.M. 1989: Ways of lowering the level of amputation in decompensated ischemia of the lower extremities Khirurgiia 3: 20-24
Liebermeister, H.; Toluipur, H. 1980: Lowering of cholesterol level by addition of pectins and soy protein to reducing diet Deutsche Medizinische Wochenschrift 105(26): 936-937
Zakharova, G.N.; Vostrikov, I.A.; Baligishiev, Z.K. 1986: Role of sympathectomy in lowering the level of amputation of the extremities in patients with endarteritis obliterans Khirurgiia 5: 72-76
Fleckenstein, A.; Pachinger, O.; Leder, O.; Hein, B.; Janke, J. 1972: Prevention of isoproterenol-induced myocardial necroses by lowering of the plasma calcium level with calcitonin Pflugers Archiv: European Journal of Physiology 332: Suppl. 332:r40
Fu, J.; Tang, H-Qin.; Qin, X-Hui.; Mao, G-Yun.; Tang, G-Fu. 2009: Efficacy of enalapril combined with folic acid in lowering blood pressure and plasma homocysteine level Zhonghua Yi Xue Za Zhi 89(31): 2179-2183
Chang, M.L.; Johnson, M.A. 1976: Influence of fat level and type of carbohydrate on the capacity of pectin in lowering serum and liver lipids of young rats Journal of Nutrition 106(11): 1562-1568
2015: Switching from high-efficacy lipid-lowering therapies [atorvastatin or rosuvastatin] to simvastatin and the results on low-density lipoprotein cholesterol level Journal of the Medical Association of Thailand 98(1): 21-25
Kaffarnik, H.; Schneider, J. 1983: Lipid lowering therapy in the elderly Münchener Medizinische Wochenschrift 125(28): 663-665
1997: What is new? Therapy with lipid lowering agents Der Internist 38(11 Suppl Therapie): 1-8
Kastelein, J.J.P. 2003: The future of lipid-lowering therapy: the big picture Netherlands Journal of Medicine 61(5 Suppl): 35-39
Simoons, M.L. 2000: Cholesterol-lowering therapy; a recommendation from the Health Council Nederlands tijdschrift voor geneeskunde 144(51): 2442-2444
He, W.; Lu, N. 2015: Emergent triglyceride-lowering therapy for hypertriglyceridemic pancreatitis Hepato-Gastroenterology 62(138): 429-434
Simoons, M.L.; Deckers, J.W. 2015: LDL cholesterol lowering therapy: no target value but personalised treatment Nederlands Tijdschrift Voor Geneeskunde 159: A8770
Luchowska, E.; Luchowski, P.; Sarnowska, A.; Wielosz, M.; Turski, W.A.; Urbańska, E.M. 2003: Endogenous level of kynurenic acid and activities of kynurenine aminotransferases following transient global ischemia in the gerbil hippocampus Polish Journal of Pharmacology 55(3): 443-447
Radermecker, R.P.; Scheen, A.J. 2010: How to optimize lipid-lowering therapy: do not forget patient's non-compliance Revue Medicale de Liege 65(5-6): 311-317
Nordmann, A.; Martina, B.; Keller, U.; Battegay, E. 1998: Lipid lowering therapy: new pathophysiologic aspects and clinical implications Schweizerische Medizinische Wochenschrift 128(17): 665-670
Bonadei, I.; Vizzardi, E.; D'aloia, A.; Gelsomino, S.; De Cicco, G.; Lorusso, R.; Dei Cas, L. 2013: Aortic valve stenosis and lipid-lowering therapy: the state of the art Panminerva Medica 55(4): 391-395
Otterstad, J.E.; Hexeberg, E.; Holme, I.; Hjermann, I. 1997: Cholesterol lowering therapy after myocardial infarction. Consequences of the CARE study Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 117(16): 2341-2344